Skip to main content
Show full summary

Lord Mendelsohn to ask Her Majesty's Government what budget they have set for the purchase of new Antiviral or Monoclonal Antibody drug treatments for COVID-19, including (1) those under current review like Evusheld, and (2) those under future review by the COVID-19 Antivirals and Therapeutics Taskforce; and if these should prove efficacious in the protection of immunosuppressed patients, whether this funding will be sufficient to meet current supply needs.  HL651

Question HL651: tabled on 6 June 2022 and due for answer by 20 June 2022

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask Her Majesty's Government what budget they have set for the purchase of new Antiviral or Monoclonal Antibody drug treatments for COVID-19, including (1) those under current review like Evusheld, and (2) those under future review by the COVID-19 Antivirals and Therapeutics Taskforce; and if these should prove efficacious in the protection of immunosuppressed patients, whether this funding will be sufficient to meet current supply needs.  HL651
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.